News $40bn Teva generic deal awaits antitrust approval Acquisition of Allergan's generics business ready.
News Impax buys Teva and Allergan generics for $586 million Teva must sell some assets before buying Allergan's generics business.
News Allergan/Gedeon Richter's uterine fibroids drug succeeds in ... Allergan and Gedeon Richter's uterine fibroid treatment ulipristal acetate, has succeeded in a phase 3 trial ahead of a planned US filing next year.
Articles Pharma news round-up: Pfizer-Allergan merger scrapped, Gilea... A round-up of this week's top pharma and healthcare news – plus reaction from social media. Marco Ricci reports.
News Pfizer to end $160bn Allergan merger after US tax changes US Treasury move means mega-merger no longer feasible
Market Access Consolidating data strategy for global success: Insights fro... At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
